White Ted's Form 4/A amendment
AmendedVerrica Pharmaceuticals Inc. (VRCA) · filed Feb 21, 2023
- Accession no.
- 0001209191-23-011127
- Filed
- Feb 21, 2023
- Trade date
- Jul 5, 2022
- Filing delay
- 231 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jul 5, 2022
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $15.8K. It was filed 231 days after the trade.
This amendment replaces 0001209191-22-040608 (filed Jul 5, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White TedCIK 0001741964 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | Common Stock | PPurchaseAcquired | +7,500 | $2.10 | +$15,750 | 29,466 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.